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Department of Laboratory Medicine, Karolinska Institutet, Stockholm and 3) Department of Laboratory Medicine, Lund University, Malmö, SwedenAbstractPapillomaviruses (PV) are a remarkably heterogeneous family of small DNA viruses that infect a wide variety of vertebrate species and are
aetiologically linked with the development of various neoplastic changes of the skin and mucosal epithelia. Based on nucleotide similarity, PVs
are hierarchically classiﬁed into genera, species and types. Novel human PV (HPV) types are given a unique number only after the whole
genome has been cloned and deposited with the International HPV Reference Center. As of 9 March 2015, 200 different HPV types,
belonging to 49 species, had been recognized by the International HPV Reference Center. In addition, 131 animal PV types identiﬁed
from 66 different animal species exist. Recent advances in molecular techniques have resulted in an explosive increase in the
identiﬁcation of novel HPV types and novel subgenomic HPV sequences in the last few years. Among PV genera, the γ-PV genus has been
growing most rapidly in recent years with 80 completely sequenced HPV types, followed by α-PV and β-PV genera that have 65 and 51
recognized HPV types, respectively. We reviewed in detail the contemporary molecular methods most often used for identiﬁcation and
characterization of novel PV types, including PCR, rolling circle ampliﬁcation and next-generation sequencing. Furthermore, we present a
short overview of 12 and 10 novel HPV types recently identiﬁed in Sweden and Slovenia, respectively. Finally, an update on the
International Human Papillomavirus Reference Center is provided.
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E-mail: mario.poljak@mf.uni-lj.siIntroductionPapillomaviruses (PV) are a large and diverse group of small,
circular, double-stranded DNA viruses, aetiologically linked to
the development of various benign and malignant lesions of the
skin and mucosa [1–3]. PVs are highly species speciﬁc, rarely
infecting even closely related animal species [3]. PVs are clas-
siﬁed into genera, species and types based on comparison of the
L1 gene sequence [1–3]. The existence of a novel HPV type isMicrobiol Infect 2015; 21: 808–816
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.05.011conﬁrmed when: (i) its complete genome has been cloned and
deposited with the International HPV Reference Center and (ii)
its L1 sequence has been found to have <90% similarity to any
other deposited clone [1,4,5].
The International HPV Reference Center, established in
1985 at the German Cancer Research Center and transferred
in 2012 to the Karolinska Institutet, Stockholm, Sweden, is
responsible for veriﬁcation of genomic sequences of novel HPV
types, assigning HPV type numbers, maintaining reference
clones and distributing samples of the reference material for
research use [6]. As of 9 March 2015, 200 different HPV types
belonging to 49 species had been recognized by the Interna-
tional HPV Reference Center (www.hpvcenter.se). The existing
HPV types belong to ﬁve PV genera: Alphapapillomavirus (α-PV),
Betapapillomavirus (β-PV), Gammapapillomavirus (γ-PV), Mupa-
pillomavirus (μ-PV) and Nupapillomavirus (ν-PV). Severalious Diseases. Published by Elsevier Ltd. All rights reserved
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next-generation sequencing (NGS), but are not yet ofﬁcially
recognized [7]. These are listed in the PapillomaVirus Episteme
(PaVE) database, together with the sequences of animal PV
genomes [7]. At present, there is no reference centre for ani-
mal PV types [1]. According to the PaVE website (http://pave.
niaid.nih.gov/), 131 animal PV types exist, identiﬁed from 66
different animal species, as of 9 March 2015. The most recent
published review on animal PVs reported 122 animal PV types,
identiﬁed from 54 different animal species [3].Identiﬁcation and Characterization of Novel
PapillomavirusesInitially, HPV genomic sequences were obtained directly from
various epithelial lesions, mainly from anogenital warts, laryn-
geal papillomas, cervical carcinomas and neoplastic lesions ob-
tained from patients suffering from epidermodysplasia
verruciformis, using a direct cloning approach. This approach is
mainly suitable for characterization of HPV types present in
high viral copy numbers. Many clinically important HPV types
(such as HPV2, HPV5, HPV6, HPV8, HPV11, HPV16, HPV18
and HPV27) were identiﬁed from the late 1970s to the mid-
1990s [4,5]. In the last two decades, PCR, rolling circle ampli-
ﬁcation (RCA), shotgun sequencing and NGS have been most
frequently used for identiﬁcation of novel PV types [5]. The
majority of PVs identiﬁed in the last two decades are β-PV and
γ-PV types found in the skin and various mucosal epithelia
[5,8–11]. Some recently discovered α-PV types and γ-PV types
seem to be aetiologically linked to the development of skin
warts, most often in immunocompromised patients [12–16].
Interestingly, more than 20 years after the second μ-PV type
was found, a third μ-PV type (HPV204) was identiﬁed only in
2014, so encouraging scientiﬁc interest in this interesting PV
genus.
Polymerase chain reaction
The most common current approach for the identiﬁcation of
novel PV types is based on PCR using various consensus or
degenerated primers (broad-range primers), designed on the
basis of multiple alignment of nucleotide or amino acid se-
quences of a large number of different HPVs. These primers
usually allow the detection of the great majority of already
known and ofﬁcially recognized HPV types but might also
detect some potentially novel types. The majority of the avail-
able broad-range PV primers, such as FAP59/FAP64, FAP6085/
FAP6319, CUT, CODEHOP, CPI/CPIIg(s), Ma/Ha, ARL1(E1)
and a collection of CP and CN primers, target the mostClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyconserved PV genomic regions, L1 and E1, which lie symmet-
rically in the circular viral genome [17–25]. Using these
primers, short (120–700-bp) subgenomic PV sequences are
usually generated. If this sequence appears to come from a
novel PV, the sequence is used to design type-speciﬁc primers
for whole genome ampliﬁcation using inverse or overlapping
long-range PCR. For inverse long-range PCR, primer pairs are
designed to anneal ‘back to back’ on a double-stranded template
to amplify the whole viral genome in a single fragment. The
obtained amplicon(s) is cloned into a plasmid vector(s) and the
viral genome sequence is usually obtained by primer walking or
Tn5 transposase-based sequencing [26]. Ampliﬁcation of large
segments of the HPV genome can be performed using special
long-range DNA polymerases, which are extremely
temperature-stable, accurate and sensitive, with ampliﬁcation
abilities up to 15-kb or longer. To increase the sensitivity of
long-range PCR, classic nested PCR or its more sensitive
version, single tube nested ’hanging droplet’ PCR, can be used
[27]. Additionally, before PCR, the PV viral load can be
increased by ampliﬁcation of the viral DNA in the sample using
RCA methodology [28].
FAP primers [17] are broad-range primers that have been
most often used in the identiﬁcation of novel HPV types in
recent years. The original FAP PCR protocol ampliﬁes a great
variety of ofﬁcially recognized HPV types from the α-PV, β-PV
and γ-PV genera. In subsequent years, these primers were used
partially to characterize more than 124 novel putative HPV
types from various mucosal and cutaneous specimens, of which
28 have been completely sequenced and ofﬁcially recognized as
novel HPV types (Table 1). In addition, 149 novel putative HPV
types were recently identiﬁed by using a combination of the
original FAP primers and their nested variants FAP6085 and
FAP6319 [29]. A large number of additional putatively novel
HPVs were identiﬁed by analysing FAP amplicons with NGS,
potentially enabling the detection of HPV types present in low-
copy numbers that would probably be otherwise missed in the
cloning procedure [30]. FAP primers have been additionally
used for identiﬁcation of several animal PV types that are only
distantly related to HPV genera [31–35], thus showing their
good performance across different PV genera.
Rolling circle ampliﬁcation
Identiﬁcation of novel (H)PV types is greatly facilitated by the
use of a special isothermal DNA ampliﬁcation technique, RCA,
enabling ampliﬁcation of any circular single- or double-stranded
DNA molecule using bacteriophage phi29 DNA polymerase
and random hexamer primers [28]. This method is character-
ized by high ﬁdelity and high amplicon yields and allows the
detection of circular viral genomes without prior knowledge of
their nucleotide sequence. By adding or independent use ofand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 808–816
TABLE 1. Twenty-eight sub-genomic FA-fragments
recognized as novel HPV types
FA-
fragment
Novel HPV
type
PV
genus
PV
species Reference
FA1.2 HPV134 Gamma 7 [73]
FA5 HPV110 Beta 2 [74]
FA8 HPV136 Gamma 11 [8]
FA13 HPV147 Gamma 8 Chen et al.,
unpublished
FA16.1 HPV120 Beta 2 [8]
FA23.1 HPV124 Beta 1 Chen et al.,
unpublished
FA28 HPV135 Gamma 15 [8]
FA35 HPV146 Gamma 15 Chen et al.,
unpublished
FA44 HPV133 Gamma 15 [73]
FA47 HPV96 Beta 5 [75]
FA51 HPV111 Beta 2 [74]
FA53 HPV100 Beta 2 [76]
FA67 HPV142 Gamma 10 Chen et al.,
unpublished
FA69 HPV180 Gamma 10 [69]
FA73 HPV141 Gamma 11 [8]
FA75 HPV104 Beta 2 [76]
FA83 HPV144 Gamma 17 [8]
FA85 HPV107 Beta 2 [74]
FA119 HPV98 Beta 1 [76]
FA136 HPV123 Gamma 7 [8]
FA137 HPV109 Gamma 7 [77]
FA147 HPV130 Gamma 10 [73]
FA155 HPV119 Gamma 7 [8]
FA164 HPV112 Gamma 7 [77]
FAIMVS2 HPV92 Beta 4 [78]
FAIMVS6.1 HPV93 Beta 4 [75]
FA.X HPV153 Gamma 13 [66]
FA.X HPV154 Gamma 11 [69]
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directed towards more speciﬁc ampliﬁcation of HPV genomes
[36].
RCA results in a product made from concatemeric repeti-
tions of the circular HPV genome, in quantities that enable
direct sequencing, restriction fragment length analysis, plasmid
cloning of the RCA fragments or their further ampliﬁcation by
PCR. Restriction analysis, cloning and Sanger sequencing of
RCA products have been the favored methods for analysis and
subsequent identiﬁcation of novel HPVs [37]. At present, RCA-
ampliﬁed samples are often sequenced directly using NGS (see
below). The wide use of RCA technology has allowed the
identiﬁcation of a large number of novel HPV types, particularly
those from the β-PV and γ-PV genera, as well as a number of
animal PVs [3,5]. In addition to circular DNA molecules, RCA
also ampliﬁes (although to a somewhat lesser extent) the linear
form of DNA [38]. RCA is therefore also called Whole
Genome Ampliﬁcation (WGA) and is widely used to amplify
whole human genomes. The capacity of RCA also to amplify the
human genome may impair the ampliﬁcation of HPV genomes if
they are present in small quantities. Various methods have
previously been tried to enhance the activity of RCA to amplify
HPV genomes, including pretreatment with exonuclease V (an
enzyme that progressively degrades linear double-stranded
DNA to deoxynucleotides), separation of 8-kb circularClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectgenomes by gel electrophoresis or density gradient centrifu-
gation in caesium chloride [38]. However, modern NGS
methods are so powerful for sequencing even low amounts of
DNA that standard RCA followed by NGS is now the most
commonly used method.
Next-generation sequencing
Next-generation or deep sequencing refers to high-throughput
sequencing technologies that allow massive parallel sequencing
of different DNA molecules in a short period of time. Several
NGS platforms are available that differ in the technology used,
the costs of sequencing and the amount of sequence data
generated [39]. NGS can be used to analyse sequencing libraries
consisting of sheared DNA samples generated, for example, by
nebulization, or amplicons generated by PCR or various
sequence-independent ampliﬁcation methods. The sensitivity of
NGS is vastly superior to Sanger sequencing, capable of
detecting mutant alleles as low as >5%, as assessed in mito-
chondrial testing [40].
In the last 5 years, partial or full-genome sequences of
several novel (H)PV types have been identiﬁed using NGS in
various bio-niches, including the skin, various head and neck
mucosal sites, the anal canal and in stool samples. NGS has
frequently been used to analyse amplicons of various PV-
speciﬁc broad-range PCRs to avoid the laborious and time-
consuming cloning procedure and selection of bacterial trans-
formants harbouring novel HPV sequences [30,41,42]. NGS has
similarly been commonly used to analyse amplicons containing
PV sequences generated by different WGA methods, including
the original RCA method [38,42–48]. Partial sequences of
several putatively novel HPV types have been identiﬁed using
NGS, including in specimens previously negative for these types
using broad-range PCR assays [42,44]. On the other hand, NGS
failed to detect numerous HPV types found with the PCR
approach in some studies [38,42]. For example, in a recent
study, NGS of FAP PCR amplicons of skin samples detected 352
different HPV types/putative novel types compared with only
26 different HPVs detected by NGS of RCA-ampliﬁed samples
[38]. However, no fewer than 11 of the HPVs that were
detected by NGS without previous PCR were not detected
when sequencing PCR amplicons. The most likely explanation is
that PCR is typically more sensitive than NGS without previous
PCR, but the fact that NGS is not dependent on any previous
knowledge of the sequences results in its better sensitivity
when there are sequence mismatches (or no sequence ho-
mology at all) to the broad-range primers used [42].
Pre-ampliﬁcation with RCA with phi29 DNA polymerase is
typically more efﬁcient on circular templates [49]. For example,
in our recent study, WGA using a GenomiPhi HighYield Ready-
to-go kit (GE Healthcare, Little Chalfont, UK) ampliﬁed theious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 808–816
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625-fold [38] and so increased the yield of HPV sequences
substantially [30,38,41,43]. WGA followed by NGS is well
suited to the detection of known and as yet unknown HPVs that
are present in biological samples [38,43,44,50]. However, as
already stated in the RCA section, the capacity of RCA addi-
tionally to amplify the human genome may impair the ampliﬁ-
cation of HPV genomes if present in low amounts. The
preference of WGA to amplify circular molecules is an
advantage when detection of PVs is desired but the lower ef-
ﬁciency for amplifying linear molecules impairs the ability to
infer how much of circular and linear viruses may have been
present in the original sample [51–53].
The approach of sequencing the DNA of a sample and then
removing the host (human) DNA sequences in the bioinfor-
matics step is called ‘metagenomics sequencing’. This approach
has been further used to determine the complete genome
sequence of several putatively novel PV types found in humans,
and also in a few animal species [38,43,54–58]. However, the
majority of these HPV types have not been cloned, deposited
and re-sequenced, and have not therefore been evaluated and
veriﬁed by the International HPV Reference Center.
Over the past several years, the throughput of NGS plat-
forms has substantially increased and the cost of sequencing per
base has decreased. The number of HPV types identiﬁed fol-
lows the increased performance of modern NGS platforms. For
example, ﬁrst-generation NGS (such as 454 GS FLX and GS
Junior platforms; Roche 454 Life Sciences, Branford, CT, USA),
found 86 putatively novel HPV types in various skin lesions
[30,41]. Analysing the same samples using a much deeper NGS
sequencing platform (MiSeq sequencer; Illumina, Inc., San
Diego, CA, USA) revealed an additional 229 previously un-
known putative HPV types [38]. As NGS is no longer prohib-
itively expensive and does not require previous knowledge of
the viral sequences present, this new technology should
fundamentally change the appearance of the HPV phylogenetic
tree landscape in the near future.
There is an ongoing debate about whether a novel complete
HPV genome obtained using metagenomic sequencing should
be ofﬁcially approved as a new HPV type, even though the virus
has not been cloned. Currently, a new HPV type is accepted
only after cloning of its complete genome, deposition of the
clone at the International HPV Reference Center, veriﬁcation of
the sequence and phylogenetic comparison with all other
deposited clones. We recently investigated the reliability of
nucleotide sequences from two novel complete HPV genomes
obtained using NGS. The complete genomes of two novel HPV
types, HPV175 (SE87) and HPV180 (FA69), were obtained by
NGS (454 technology), as well as by the use of Sanger
sequencing of corresponding cloned PCR products. CompleteClinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyHPV sequences generated by both methods demonstrated
100% sequence identity. We deem that the reliability of NGS-
derived sequences is sufﬁcient and that ofﬁcial recognition of a
new HPV type does not need to be refused for NGS-derived
sequences on the grounds of reliability. The advantage of in-
ternational Open Access availability for research of deposited
reference clones for each HPV type is therefore the major
argument for the current requirement of cloning and deposi-
tion of the clone for ofﬁcial recognition of an HPV type.A Review of Novel Papillomaviruses
Identiﬁed in SloveniaIn the last decade, the laboratory in Ljubljana, Slovenia, has
identiﬁed and completely characterized ten novel HPVs and one
novel animal PV. We additionally identiﬁed partial nucleotide
sequences of 65 potentially novel HPVs (marked with the
symbol SIBX in the order of their identiﬁcation). The majority
of these viruses belong to the currently fastest growing PV-
genera: β-PV and γ-PV. Partial nucleotide sequences of novel
(H)PVs were mainly obtained using various broad-range PCR
protocols, followed by ampliﬁcation of the entire viral genome
using long-range type-speciﬁc PCR, and the determination of
the complete viral nucleotide sequence by primer walking. The
main features and characteristics of novel HPV types are
summarized in the Supplementary material (Table S1).
HPV125
HPV125 was initially identiﬁed in 2004 as isolate SIBX9 in a hand
common wart obtained from a 19-year-old immunocompetent
patient, and completely characterized in 2011 [13]. HPV125
shows typical genome organization and is phylogenetically clas-
siﬁed in the α-PV genus, species α-2, which includes several HPV
types aetiologically linked with skin warts. Testing of a repre-
sentative collection of HPV-associated mucosal and cutaneous
benign and malignant neoplasms and hair follicles showed that
HPV125 is a relatively rare HPV type, with cutaneous tropism
aetiologically linked to sporadic cases of common warts.
HPV150 and HPV151
These were initially identiﬁed in 2005 as isolates SIBX1 and
SIBX2, respectively, in the eyebrows of patients with anogenital
warts [59] and completely characterized as novel β-PV types in
2011 [60]. Phylogenetically, HPV150 clusters to species β-5 and
is most closely related to HPV96, whereas HPV151 clusters to
species β-2 and is most closely related to HPV22. Using RT-
PCR, both novel types were further detected in hair follicles
and benign and malignant skin neoplasms as single or multiple
infections, usually with low viral loads.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 808–816
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HPV120 was initially identiﬁed in 2005 as isolate SIBX3 in the
eyebrows of a patient with anogenital warts [59]. The com-
plete viral genome, phylogenetically placed in the β-PV genus,
species β-2 (its closest relative is HPV23), was characterized
simultaneously in 2012 from an anal canal sample from a pa-
tient with anogenital warts in Slovenia and from oral cavity
samples of patients with prostate cancer in the USA [61].
HPV120 has further been detected in heterogeneous human
biological niches, including the oral cavity, eyebrow hairs, anal
canal and penile, vulvar and perianal warts, indicating a broader
spectrum of epithelial tropism than appreciated previously for
β-PVs.
HPV159
HPV159 was initially identiﬁed in 2006 as isolate SIBX8 in
anogenital hair follicles [62], and completely characterized 7
years later from the anal canal sample of a patient suffering from
anogenital warts [63]. HPV159, which exhibits both cutaneous
and mucosal tropism, is phylogenetically placed in the β-PV
genus, species β-2, and is most closely related to HPV9.
HPV174
HPV174 was completely characterized in 2013 from a cuta-
neous squamous cell carcinoma sample additionally containing
HPV9 and HPV150 [64]. HPV174 belongs to the β-PV genus,
species β-2, and is most closely related to HPV145.
HPV179 and HPV184
These were initially identiﬁed in 2013 as isolates SIBX16 and
SIBX17 from two distinct facial common warts of a 64-year-old
renal-transplant recipient and completely characterized in 2014
[16]. HPV179 and HPV184 are taxonomically placed within the
γ-PV genus—HPV179 is a novel member of species γ-15
(additionally containing HPV135 and HPV146), whereas
HPV184 is a single member of a novel species γ-25. HPV179
and HPV184 are relatively rare HPV types, with cutaneous and
mucosal tissue tropism, aetiologically linked to sporadic cases of
common warts, probably more often in immunosuppressed
patients [16].
HPV199
HPV199 was initially identiﬁed in 2013 in China as isolate KC82
(GenBank Accession No. KC752084) from a skin swab sample
obtained from a healthy individual and completely characterized
in 2014 from a nasopharyngeal swab sample obtained from a
25-year-old immunocompetent Slovenian patient. HPV199 be-
longs to the γ-PV genus, species γ-12, and is most closely
related to HPV127. Studies to deﬁne its tissue tropism/predi-
lection and clinical signiﬁcance are in progress.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectHPV204
HPV204 was initially identiﬁed in 2009 in Argentina as isolate
GC03 (GenBank Accession No. FJ947082) from a skin swab
sample obtained from a healthy individual, and completely
characterized in 2014 from anogenital warts of a 42-year-old
immunocompetent Slovenian patient. HPV204 is phylogeneti-
cally positioned in the μ-PV genus as a new type in a new μ-PV
species. The potential clinical importance and tissue tropism/
predilection of this novel μ-PV type is under investigation.
PsuPV1
We recently identiﬁed the ﬁrst PV—Phodopus sungorus papil-
lomavirus type 1, PsuPV1, whose natural host is the Siberian
hamster (Phodopus sungorus) [34]. PsuPV1 is taxonomically
placed in the πi-PV genus, currently consisting of PV types
isolated from various rodent species, including Syrian hamster,
various mouse species and Brown rat (Rattus norvegicus).
PsuPV1 is most closely related to MaPV1 isolated from the oral
cavity of a Syrian hamster (Mesocricetus auratus) [65].A Review of Novel Papillomaviruses
Identiﬁed in SwedenA series of novel HPV types have been recently identiﬁed in
either Malmö or Stockholm in Sweden and were originally
ampliﬁed as subgenomic amplicons by the use of FAP-PCR [17].
The main features and characteristics of novel HPV types are
summarized in the Supplementary material (Table S1).
HPV153
HPV153 species γ-13, was originally identiﬁed by FAP-PCR
from RCA-ampliﬁed material from a genital wart swab sample
[66]. The complete genome of HPV153 was then obtained after
long-range PCR and cloning [66].
HPV154
HPV154 species γ-11, was ﬁrst identiﬁed by FAP-PCR from a
swab of a wart at the intergluteal cleft of a three-year-old boy
[67]. The complete genome was obtained by combination of
RCA, genome walking through an adapted method for detec-
tion of integrated PV sequences by ligation-mediated PCR
(DIPS-PCR), long-range PCR and, ﬁnally, by cloning of four
overlapping amplicons of RCA-ampliﬁed material. HPV154 has
been detected in 3% (2/62) of forehead skin swabs from healthy
children [67].
HPV180
HPV180 species γ-10, initially designated FA69, was initially
identiﬁed in 2003 by FAP-PCR from healthy skin [68]. Severalious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 808–816
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a Roche 454 GS Junior sequencer after whole genomic ampli-
ﬁcation of DNA isolated from a genital wart swab sample [44].
The complete genome of HPV180 was cloned as a single
amplicon after ampliﬁcation with RCA [69].
NGS without previous PCR for detection and sequencing,
followed by long-range PCR with type-speciﬁc primers, was
used to isolate the following novel HPV types.
HPV155
HPV155 species γ-7, initially designated isolate SE42, was
identiﬁed by metagenomic analysis of an actinic keratosis swab
sample [43]. Analysis with 454 sequencing and Ion Torrent
PGM (Life Technologies, Guilford, CT, USA) sequencing
revealed two contigs and one contig of the SE42, respectively.
The complete genome of HPV155 was subsequently obtained
as three overlapping fragments after long-range PCR and
cloning [43]. Further studies revealed that HPV155 is present in
1.1% (4/341) and 2.1% (7/341) of swab samples obtained from
various skin lesions and healthy skin, respectively.
HPV175
HPV175 species γ-23, initially designated isolate SE87, was
identiﬁed as a complete genome by NGS using a Roche 454
GS Junior sequencer after WGA of a genital wart swab
sample [44]. The complete genome of HPV175 was cloned as
three overlapping amplicons from WGA-ampliﬁed material
[69].FIG. 1. Alignment of FAP59 (a) and
FAP64 primer (b) sequences with the
corresponding region of the L1 open
reading frame of 14 novel PV types.
HPV type 155 (HPV155), HPV175,
HPV178, HPV197, HPV200, HPV201
and HPV202 were detected by met-
agenomic sequencing only. HPV198
and HPV203 were detected by met-
agenomic sequencing after successful
PCR with FAP-primers. Camelus
dromedarius papillomavirus types 1
and 2 (CdPV1 and 2) were originally
detected by PCR with FAP-primers.
Lines and characters represent iden-
tical and mismatched nucleotides,
respectively. The sequence of the
FAP64 primer is marked with an
asterisk.
Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyHPV178
HPV178 species γ-24, was obtained from a swab sample of
healthy skin, adjacent to an actinic keratosis, after an attempt to
amplify the closely related SE46 isolate [42,69]. The complete
genome of HPV178 was cloned as a single amplicon after
ampliﬁcation of WGA-ampliﬁed material [69].
HPV197
HPV197 species γ-24, initially designated isolate SE46, was
identiﬁed as a complete genome by NGS from a formalin-ﬁxed,
parafﬁn-embedded tissue sample of cutaneous squamous cell
carcinoma of the skin [42]. The complete genome of HPV197
was cloned as three overlapping amplicons [42]. HPV197 was
identiﬁed in 12/24 tissue samples of cutaneous squamous cell
carcinoma of the skin.
HPV198 and HPV203
HPV198 species β-2 and HPV203, initially designated SE22 and
SE3, respectively, were identiﬁed by NGS of FAP amplicons
from frozen biopsies of actinic keratosis and squamous cell
carcinoma, respectively [41]. The complete genomes of
HPV198 and HPV203 were cloned as two overlapping frag-
ments each.
HPV200, HPV201 and HPV202
HPV200 species γ-2, HPV201, species γ-27, HPV202, species
γ-11, were identiﬁed by NGS in swab samples of genital warts
that were initially ‘HPV-negative’ by PCR (unpublished data).and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 808–816
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cloned as two overlapping fragments each. Interestingly, these
three HPV types were not detected by FAP-PCR, probably
because of deleterious nucleotide mismatches between the
FAP-primers and these HPV types (Fig. 1). Such mismatches
may result in novel HPV types being mostly detected in the
future by NGS without previous PCR.Update on the International HPV Reference
CenterNovel HPV types are given a unique number only after the
whole genome has been cloned and deposited with the Inter-
national HPV Reference Center [1,4,6]. The Papillomavirus
nomenclature at the species level and above is determined by
the PV study group of the International Committee on Tax-
onomy of Viruses [1,4,70].
Since 2012, when the International HPV Reference Center
was transferred to the Karolinska Institutet, 34 clones have
been conﬁrmed as novel HPV types and assigned ofﬁcial
numbers. Twenty-six of them cluster in the γ-PV genus, six
types in the β-PV genus, one new type in the α-PV genus and
one in the μ-PV genus. As of 9 March 2015, the highest HPV
type number awarded is HPV204. Because four previously
awarded HPV type numbers (HPV46, HPV55, HPV64, HPV79)
were withdrawn, as of 9 March 2015 there are 200 different
HPV types established.
The γ-PV genus has been growing rapidly, now with 80
completely sequenced types. It now surpasses the α- and β-PV
genera, which have only 65 and 51 recognized HPV types,
respectively. The μ-PV and ν-PV genera are represented by
only four HPV types (HPV1, HPV63, HPV204 and HPV41). It is
somewhat surprising that only one new μ-PV type (HPV204)
has been found in recent years, although modern methods for
virus detection are independent of the virus sequences (i.e.
metagenomic sequencing) and the low PCR-ampliﬁability of
these genera caused by mismatches with the broad HPV general
primers should not have any inﬂuence on the ability to detect
viruses in these genera. We speculate that novel HPV types of
the μ-PV genus are rarely detected because of their presence in
minute quantities in the skin (low viral load) and/or as the result
of rapid and successful clearance of infection by the immune
system.
The International HPV Reference Center provides the ser-
vice of comparing putatively novel HPV types against sequences
of all previously submitted clones and then informs the origi-
nating scientist whether the sequence is really novel or whether
a clone with the sequence has already been submitted [6]. ThisClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectservice is considered important for avoiding duplication of
work and for prioritization of cloning efforts.
The International HPV Reference Center also maintains
reference clones and distributes samples of the reference ma-
terial for research use, if it is allowed by material transfer
agreement with the clone owners [6]. The maintenance of a
central repository of reference clones is considered essential to
ensure that different laboratories have easy access to key re-
agents and that they work on similar materials. Since 2013, the
Reference Center has provided no fewer than 90 different
reference clones to 21 different academic research laboratories
worldwide [6].
The International HPV Reference Center also designs and
coordinates international proﬁciency testing panels for evalua-
tion of the ability accurately to genotype different HPVs in
different laboratories. This is a continuation of an effort that
was started by the WHO in 2005. The WHO global HPV
Laboratory Network (LabNet) was established to develop
internationally comparable quality assurance procedures in
HPV testing and genotyping worldwide by, for example, issuing
proﬁciency panels and standards as well as a WHO laboratory
manual for recommended procedures [71,72].Transparency DeclarationThe authors declare no conﬂicts of interest.AcknowledgementsThis work was partially supported by the European Union’s
Seventh Framework Programme for research, technological
development and demonstration under CoheaHr project (grant
agreement No. HEALTH-F3-2013-603019).Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
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